Stock Market Lupin shares jump 2% after company signs licensing and supply agreement with… Aman Shukla Jul 9, 2025
Corporates Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market Aman Shukla Jul 4, 2025
Corporates Lupin gets USFDA nod for Loteprednol Etabonate Ophthalmic Gel; Eligible for… Aman Shukla Jul 1, 2025
Corporates Lupin carves out LupinLife into separate consumer healthcare subsidiary to focus… Aman Shukla Jul 1, 2025
Corporates Lupin gets U.S. FDA nod for Prucalopride Tablets for treatment of CIC in adults Aman Shukla Jun 25, 2025
Stock Market Lupin shares in focus after US Court rejects plea in Astellas Patent case Aman Shukla Jun 13, 2025
Corporates Lupin gets U.S. FDA tentative approval for Generic Oxcarbazepine ER Tablets Aman Shukla Jun 7, 2025
Stock Market Top stocks to watch today, May 27: Lupin, Aurobindo Pharma, NHPC, KEC… Aman Shukla May 27, 2025
Corporates Lupin and SteinCares sign license and supply agreement for Ranibizumab in Latin… Aman Shukla May 26, 2025
Corporates Lupin secures FDA approval for Rivaroxaban 10 mg, 15 mg and 20 mg tablets Aman Shukla May 15, 2025
Corporates Lupin receives U.S. FDA approval for Tolvaptan tablets with 180-day exclusivity Aditya Bhagchandani Apr 24, 2025
Corporates Lupin receives EIR from US FDA for its injectable manufacturing facility in Nagpur Aman Shukla Apr 17, 2025
Stock Market Stocks to watch today: Wipro, Zydus, Lupin, KEI, L&T, Bharti Airtel, IndiGo… News Desk Apr 17, 2025
Corporates Lupin: Business Model, Q3 FY25 Earnings, Promoter Details, and Shareholding… Aditya Bhagchandani Apr 6, 2025
Stock Market Lupin shares jump 6% as U.S. spares pharma exports from 26% tariff Aman Shukla Apr 3, 2025
Corporates Lupin launches FDA-approved Rivaroxaban Tablets USP, 2.5 mg in the US Aman Shukla Mar 7, 2025
Corporates Lupin’s Somerset plant receives FDA approval following successful inspection Aman Shukla Feb 21, 2025
Stock Market Lupin shares surge 5% as HSBC maintains ‘Buy’ rating with Rs 2,565 target Aman Shukla Feb 13, 2025
